Filing Details
- Accession Number:
- 0001181431-10-054401
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-09 16:51:07
- Reporting Period:
- 2010-11-05
- Filing Date:
- 2010-11-09
- Accepted Time:
- 2010-11-09 16:51:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1325879 | Aveo Pharmaceuticals Inc | AVEO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1486428 | William Slichenmyer | C/O Aveo Pharmaceuticals, Inc. 75 Sidney Street Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-11-05 | 200 | $9.64 | 200 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-11-05 | 200 | $17.00 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-11-08 | 1,800 | $9.64 | 1,800 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-11-08 | 1,800 | $17.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2010-11-05 | 200 | $0.00 | 200 | $9.64 |
| Common Stock | Stock Option (right to buy) | Disposition | 2010-11-08 | 1,800 | $0.00 | 1,800 | $9.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 184,300 | 2019-10-08 | No | 4 | M | Direct | |
| 182,500 | 2019-10-08 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2010.
- The option will vest as to 25% of the shares on September 14, 2010 and on equal monthly installments thereafter as to the remaining shares through September 14, 2013.
Billionaire Hedge Funds
